EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells



Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells



Cytometry. 34(3): 128-142, E 15



The need for a rapid and reliable marker for the engraftment potential of hematopoietic stem and progenitor cell (HPC) transplants has led to the development of flow cytometric assays to quantitate such cells on the basis of their expression of CD34. The variability associated with enumeration of low-frequency cells (i.e., as low as 0.1% or 5 cells/mul) is exceedingly large, but recent developments have improved the accuracy and precision of the assay. Here, we review and compare the major techniques. Based on the current state of the art, we recommend 1) bright fluorochrome conjugates of class II or III monoclonal antibodies (mAbs) that detect all glycoforms of CD34, 2) use of a vital nucleic acid dye to exclude platelets, unlysed red cells, and debris or use of 7-amino actinomycin D to exclude dead cells during data acquisition, 3) counterstaining with CD45 mAb to be included in the definition of HPC, 4) during list mode data analysis, Boolean gating to resolve the CD34+ HPCs from irrelevant cell populations on the basis of the low levels of CD45 expression and low sideward light-scatter signals of HPCs, 5) inclusion of CD34dim and CD34bright populations in the CD34+ cell count, 6) omission of the negative control staining, and 7) for apheresis products, enumeration of at least 100 CD34+ cells to ensure a 10% precision. Unresolved technical questions are 1) the replacement of conventional dual-platform by single-platform assay formats, i.e., derivation of absolute CD34+ cell counts from a single flow cytometric assessment instead of from combined flow cytometer (percent CD34+) and hematology analyzer (absolute leukocyte count) data, 2) the cross-calibration of the available single-platform assays, and 3) the optimal method for sample preparation. An important clinical question to be addressed is the definition of the precise phenotypes and required numbers of HPCs responsible for short- and long-term recovery to optimize HPC transplant strategies.

Accession: 008692637

Download citation: RISBibTeXText

DOI: 10.1002/(sici)1097-0320(19980615)34:3<128::aid-cyto3>3.0.co;2-d

Download PDF Full Text: Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells



Related references

Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis. Cytometry 34(3): 128-142, 1998

Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells in leukapheresis product and bone marrow for clinical transplantation: a comparison of three methods. Folia Histochemica et Cytobiologica 44(1): 53-60, 2006

The new Sysmex XN-2000 automated blood cell analyzer more accurately measures the absolute number and the proportion of hematopoietic stem and progenitor cells than XE-2100 when compared to flow cytometric enumeration of CD34+ cells. Annals of Laboratory Medicine 35(1): 146-148, 2016

Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells. Journal of Biological Regulators & Homeostatic Agents 15(1): 14-22, January-March, 2001

North American Multicenter Study on flow cytometric enumeration of CD34+ hematopoietic stem cells. Journal of HematoTherapy 5(3): 227-236, 1996

Enumeration of CD34+ hematopoietic stem and progenitor cells. Current Protocols in Cytometry Chapter 6: Unit 6.4-Unit 6.4, 2008

The diversity of human hematopoietic stem/progenitor cells. I. Two-color flow cytometric analysis of the different functional subpopulations of CD 34+ hematopoietic stem/progenitor cells riched from human bone marrow. Shi Yan Sheng Wu Xue Bao 29(1): 49-57, 1996

Use of flow cytometric CD34 analysis to quantify hematopoietic progenitor cells. Leukemia & Lymphoma 10(6): 443-451, 1993

Thy-1 and c-kit receptor expression on CD34+ hematopoietic progenitor cells A five dimensional flow cytometric study. Haematologica 83(7): 587-592, July, 1998

Ambulance Equipments. Hospital 14(360): 335-336, 2018

Thy-1 (CDw90) and c-kit receptor (CD117) expression on CD34+ hematopoietic progenitor cells: a five dimensional flow cytometric study. Haematologica 83(7): 587-592, 1998

Enumeration of CD34+ hematopoietic progenitor cells in peripheral blood and leukapheresis products by microvolume fluorimetry: a comparison with flow cytometry. Journal of HematoTherapy 6(4): 291-301, 1997

Direct volumetric flow cytometric quantitation of CD34+ stem and progenitor cells. Transfusion Medicine 22(3): 205-210, 2012

Flow cytometric detection of apoptosis using HO33342 fluorescent dye in bone marrow CD34+ hematopoietic progenitor cells from cancer patients. Blood 98(11 Part 2): 137b, November 16, 2001